Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis



Rating:

Share or cite this content

Citations should be made in the following way:
K. Adler (Raleigh, Nc, United States of America). From Bench to edside: Development of a drug to treat lung disease from a basic research start. Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis

Member's Comments

No comment yet.

Related content which might interest you: Development of a pulmonary nodule service & clinical pathway: A pragmatic approach addressing an unmet need Source: International Congress 2016 – Quality management and quality of life in lung cancer Year: 2016 Biomarkers for fibrotic lung disease - new clinical benchmarks from the lab? Source: Annual Congress 2013 –ME3 Biomarkers for fibrotic lung disease – new clinical benchmarks from the lab? Year: 2013 Filling in the gaps- Translational research to develop new therapies  Source: International Congress 2017 – Bronchiectasis: from guidelines to real life Year: 2017 Translating research into practice: how are guidelines implemented? Source: Eur Respir J 2003; 21: 23S-29S Year: 2003 Value of animal models. Lessons learnt from another therapeutic area: implications for respiratory disease Source: Annual Congress 2007 - PG11 - Translation of animal models to human airway disease Year: 2007 Reading list SW15 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Source: International Congress 2016 – SW15 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Year: 2016 Reading list SW11 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Source: International Congress 2016 – SW11 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Year: 2016 Use of national disease registries in the conduct of long-term post-authorisation drug safety studies (LTSSs) Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016 Occupational COPD : what is new and how do we identify and ultimately prevent this disease? Source: International Congress 2019 – PG13 Traditional and modern clinical approaches for diagnosis and management of occupational airways diseases Year: 2019 Drug development: news from “hot” early stage clinical trials: personalised immunotherapy for lung cancer Source: International Congress 2017 – Scientific year in review Year: 2017 Advances in treatment of complex lung disease: will targeted therapy with anticalins be clinically applied in the near future? Source: International Congress 2019 – Inhaled medicines and biological therapies in the current era of systemic treatments Year: 2019 Family integration in pulmonary rehabilitation programmes: A pilot study Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 1) Year: 2013 Human translational medicine in ILD: the promise of new drugs Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 H2020 funding for respiratory research: scaling up for the prevention and treatment of lung diseases Source: Eur Respir J, 54 (3) 1901417; 10.1183/13993003.01417-2019 Year: 2019 COPD case-finding application: SYNERGY project Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013 Response to pulmonary rehabilitation: toward personalised programmes? Source: Eur Respir J 2015; 46: 1538-1540 Year: 2015 Talk from Athens – Genetics: diagnosing, counseling, and optimising therapy in fibrotic lung diseases Source: ERS Satellites 2019 Year: 2019 Evaluating COPD disease management: application of a theoretical model Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008 Programme SW15 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Source: International Congress 2016 – SW15 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Year: 2016